×
About 884 results

ALLMedicine™ Pediatric Multiple Sclerosis Center

Research & Reviews  429 results

Early predictors of 9-year disability in pediatric multiple sclerosis.
https://doi.org/10.1002/ana.26052
Annals of Neurology; De Meo E, Bonacchi R et. al.

Feb 18th, 2021 - To assess early predictors of 9-year disability in pediatric multiple sclerosis patients. Clinical and MRI assessments of 123 pediatric multiple sclerosis patients were obtained at disease onset and after 1 and 2 years. A 9-year clinical follow-up...

Characteristics of pediatric multiple sclerosis: A tertiary referral center study.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710048
PloS One; Nikolić B, Ivančević N et. al.

Dec 2nd, 2020 - The present study represents one of the largest series of pediatric multiple sclerosis (PedMS) in Western Balkan region. This is the first study aimed to evaluate the characteristics of PedMS in the Serbian population. This retrospective study on ...

Langerhans cell histiocytosis in children: A retrospective case series of 126 cases.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710048
Pediatric Dermatology REFERENCES; Dhar S, Srinivas SM et. al.

Sep 27th, 2020 - The present study represents one of the largest series of pediatric multiple sclerosis (PedMS) in Western Balkan region. This is the first study aimed to evaluate the characteristics of PedMS in the Serbian population. This retrospective study on ...

School performance, psychiatric comorbidity, and healthcare utilization in pediatric mu...
https://doi.org/10.1177/1352458520959673
Multiple Sclerosis (Houndmills, Basingstoke, England); Boesen MS, Blinkenberg M et. al.

Sep 25th, 2020 - Pediatric multiple sclerosis (MS) may hamper educational achievements due to psychiatric comorbidity and cognitive impairment. Our aims were to investigate school performance, psychiatric comorbidity, and healthcare utilization following pediatric...

Pediatric Multiple Sclerosis Severity Score in a Large U.S. Cohort.
https://doi.org/10.1212/WNL.0000000000010414
Neurology Santoro JD, Waltz M et. al.

Jul 21st, 2020 - To characterize disease severity and distribution of disability in pediatric-onset multiple sclerosis (POMS) and to develop an optimized modeling scale for measuring disability we performed a multi-center retrospective analysis of disability score...

see more →

Guidelines  1 results

International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple ...
https://doi.org/10.1177/1352458513484547
Multiple Sclerosis (Houndmills, Basingstoke, England); Krupp LB, Tardieu M et. al.

Apr 10th, 2013 - There has been tremendous growth in research in pediatric multiple sclerosis (MS) and immune mediated central nervous system demyelinating disorders since operational definitions for these conditions were first proposed in 2007. Further, the Inter...

see more →

Clinicaltrials.gov  441 results

Early predictors of 9-year disability in pediatric multiple sclerosis.
https://doi.org/10.1002/ana.26052
Annals of Neurology; De Meo E, Bonacchi R et. al.

Feb 18th, 2021 - To assess early predictors of 9-year disability in pediatric multiple sclerosis patients. Clinical and MRI assessments of 123 pediatric multiple sclerosis patients were obtained at disease onset and after 1 and 2 years. A 9-year clinical follow-up...

Characteristics of pediatric multiple sclerosis: A tertiary referral center study.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710048
PloS One; Nikolić B, Ivančević N et. al.

Dec 2nd, 2020 - The present study represents one of the largest series of pediatric multiple sclerosis (PedMS) in Western Balkan region. This is the first study aimed to evaluate the characteristics of PedMS in the Serbian population. This retrospective study on ...

Langerhans cell histiocytosis in children: A retrospective case series of 126 cases.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710048
Pediatric Dermatology REFERENCES; Dhar S, Srinivas SM et. al.

Sep 27th, 2020 - The present study represents one of the largest series of pediatric multiple sclerosis (PedMS) in Western Balkan region. This is the first study aimed to evaluate the characteristics of PedMS in the Serbian population. This retrospective study on ...

School performance, psychiatric comorbidity, and healthcare utilization in pediatric mu...
https://doi.org/10.1177/1352458520959673
Multiple Sclerosis (Houndmills, Basingstoke, England); Boesen MS, Blinkenberg M et. al.

Sep 25th, 2020 - Pediatric multiple sclerosis (MS) may hamper educational achievements due to psychiatric comorbidity and cognitive impairment. Our aims were to investigate school performance, psychiatric comorbidity, and healthcare utilization following pediatric...

Pediatric Multiple Sclerosis Severity Score in a Large U.S. Cohort.
https://doi.org/10.1212/WNL.0000000000010414
Neurology Santoro JD, Waltz M et. al.

Jul 21st, 2020 - To characterize disease severity and distribution of disability in pediatric-onset multiple sclerosis (POMS) and to develop an optimized modeling scale for measuring disability we performed a multi-center retrospective analysis of disability score...

see more →

News  11 results

Pediatric MS often goes untreated in the year after diagnosis
https://www.mdedge.com/neurology/article/202447/multiple-sclerosis/pediatric-ms-often-goes-untreated-year-after-diagnosis?channel=251
Jake Remaly

Jun 6th, 2019 - SEATTLE – About 65% of patients with pediatric multiple sclerosis (MS) do not receive disease-modifying therapy (DMT) within 1 year of diagnosis, according to an analysis of insurance claims data. Females may be more likely than males to receive D.

PARADIGMS: Fingolimod Effective, Well Tolerated in Children
https://www.staging.medscape.com/viewarticle/901996

Sep 13th, 2018 - Children and adolescents with multiple sclerosis (MS) who are treated with fingolimod have a much lower relapse rate than those receiving interferon β-1a, although they may experience more seizures or other adverse events, phase 3 results of the P...

Pediatric Multiple Sclerosis: A Game-Changing New Therapy
https://www.medscape.com/viewarticle/901407

Sep 13th, 2018 - Good morning. My name's Brenda Banwell. I'm the chief of neurology at the Children's Hospital of Philadelphia. I serve as the director of the Pediatric Multiple Sclerosis Clinic at CHOP. I recently served as one of the co–principal investigators o...

PARADIGMS: Fingolimod Effective, Well Tolerated in Children
https://www.medscape.com/viewarticle/901996

Sep 13th, 2018 - Children and adolescents with multiple sclerosis (MS) who are treated with fingolimod have a much lower relapse rate than those receiving interferon β-1a, although they may experience more seizures or other adverse events, phase 3 results of the P...

Pediatric MS gets a win with fingolimod
https://www.mdedge.com/neurology/article/167029/multiple-sclerosis/pediatric-ms-gets-win-fingolimod
Michele G. Sullivan

May 31st, 2018 - NASHVILLE, TENN. – Pediatric multiple sclerosis is a confirmed clinical entity, which virtually always presents as relapsing-remitting disease, Brenda Banwell, MD, said at the at the annual meeting of the Consortium of Multiple Sclerosis Centers.

see more →

Patient Education  2 results see all →